Trials / Completed
CompletedNCT00346866
Anecortave Acetate Versus Placebo in AMD Patients Following PDT
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 136 (planned)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to evaluate the efficacy of anecortave acetate for depot suspension (30 mg and 15 mg) plus PDT versus PDT alone with respect to maintenance of visual acuity in patients with wet AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | anecortave acetate |
Timeline
- Start date
- 2000-05-01
- Primary completion
- 2001-12-01
- Completion
- 2001-12-01
- First posted
- 2006-06-30
- Last updated
- 2008-08-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00346866. Inclusion in this directory is not an endorsement.